Stillfront Group AB (publ) (STLFF)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	263	379	627	863	2,068	4,185
Market Cap Growth	-26.20%	-39.51%	-27.33%	-58.29%	-50.58%	303.86%
Enterprise Value	701	758	1,048	1,232	2,344	4,336
Last Close Price	0.50	0.75	1.20	1.77	5.09	108.29
PE Ratio	-	-	900.53	16.09	31.69	59.25
PS Ratio	0.37	0.58	0.83	1.17	3.15	7.94
PB Ratio	0.38	0.56	0.46	0.63	1.91	5.59
P/FCF Ratio	1.52	2.52	3.79	4.57	13.53	27.90
P/OCF Ratio	1.50	2.49	3.73	4.43	11.54	27.47
EV/Sales Ratio	1.00	1.16	1.39	1.67	3.57	8.23
EV/EBITDA Ratio	5.83	6.77	7.07	6.97	13.56	30.05
EV/EBIT Ratio	13.15	14.08	14.15	12.64	20.68	36.08
EV/FCF Ratio	4.05	5.04	6.34	6.53	15.34	28.91
Debt / Equity Ratio	0.77	0.94	0.50	0.55	0.81	0.82
Debt / EBITDA Ratio	4.44	5.52	4.53	4.14	4.96	4.11
Debt / FCF Ratio	3.09	4.22	4.20	3.99	5.77	4.06
Asset Turnover	0.36	0.37	0.32	0.35	0.37	0.53
Quick Ratio	1.23	0.91	1.08	0.82	0.63	1.04
Current Ratio	1.23	0.95	1.13	0.85	0.65	1.07
Return on Equity (ROE)	-69.33%	-69.18%	0.09%	4.55%	7.48%	14.31%
Return on Assets (ROA)	1.70%	1.91%	1.99%	2.88%	3.95%	7.51%
Return on Capital (ROIC)	2.02%	2.11%	2.17%	3.19%	4.43%	8.41%
Return on Capital Employed (ROCE)	3.90%	4.10%	3.50%	4.60%	6.00%	9.00%
Earnings Yield	-292.22%	-175.81%	0.11%	6.22%	3.16%	1.69%
FCF Yield	65.90%	39.70%	26.37%	21.88%	7.39%	3.58%
Buyback Yield / Dilution	1.58%	-0.01%	-5.85%	-31.80%	-12.78%	-28.52%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.